Managing Board

Michael Schlenk, CEO

Diplom-Kaufmann (University of Hamburg)
M.B.A (University of Bradford, UK)

25 years in the pharmaceutical industry, more than 20 years experience as CEO, Business Angel and active investor in the growing biotech-market. Management positions in Germany and more than 10 countries e.g. with Sandoz, Novartis, ProBioGen. Last position as CEO with Centogene Holding; since June 2014 Member of Supervisory Board and investor. With curasan since 2014.